Literature DB >> 17119115

Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma.

Yazan Alsayed1, Hai Ngo, Judith Runnels, Xavier Leleu, Ujjal K Singha, Costas M Pitsillides, Joel A Spencer, Teresa Kimlinger, Joanna M Ghobrial, Xiaoying Jia, Ganwei Lu, Michael Timm, Ashok Kumar, Daniel Côté, Israel Veilleux, Karen E Hedin, G David Roodman, Thomas E Witzig, Andrew L Kung, Teru Hideshima, Kenneth C Anderson, Charles P Lin, Irene M Ghobrial.   

Abstract

The mechanisms by which multiple myeloma (MM) cells migrate and home to the bone marrow are not well understood. In this study, we sought to determine the effect of the chemokine SDF-1 (CXCL12) and its receptor CXCR4 on the migration and homing of MM cells. We demonstrated that CXCR4 is differentially expressed at high levels in the peripheral blood and is down-regulated in the bone marrow in response to high levels of SDF-1. SDF-1 induced motility, internalization, and cytoskeletal rearrangement in MM cells evidenced by confocal microscopy. The specific CXCR4 inhibitor AMD3100 and the anti-CXCR4 antibody MAB171 inhibited the migration of MM cells in vitro. CXCR4 knockdown experiments demonstrated that SDF-1-dependent migration was regulated by the P13K and ERK/ MAPK pathways but not by p38 MAPK. In addition, we demonstrated that AMD3100 inhibited the homing of MM cells to the bone marrow niches using in vivo flow cytometry, in vivo confocal microscopy, and whole body bioluminescence imaging. This study, therefore, demonstrates that SDF-1/CXCR4 is a critical regulator of MM homing and that it provides the framework for inhibitors of this pathway to be used in future clinical trials to abrogate MM trafficking.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17119115      PMCID: PMC1852222          DOI: 10.1182/blood-2006-07-035857

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  50 in total

1.  Role of metalloproteinases MMP-9 and MT1-MMP in CXCL12-promoted myeloma cell invasion across basement membranes.

Authors:  Marisa Parmo-Cabañas; Isabel Molina-Ortiz; Salomón Matías-Román; David García-Bernal; Xonia Carvajal-Vergara; Inmaculada Valle; Atanasio Pandiella; Alicia G Arroyo; Joaquin Teixidó
Journal:  J Pathol       Date:  2006-01       Impact factor: 7.996

2.  The involvement of stromal derived factor 1alpha in homing and progression of multiple myeloma in the 5TMM model.

Authors:  Eline Menu; Kewal Asosingh; Stefano Indraccolo; Hendrik De Raeve; Ivan Van Riet; Els Van Valckenborgh; Isabelle Vande Broek; Isabelle Van de Broek; Nobutaka Fujii; Hirokazu Tamamura; Ben Van Camp; Karin Vanderkerken
Journal:  Haematologica       Date:  2006-04-19       Impact factor: 9.941

Review 3.  Compartmentalized Ras/MAPK signaling.

Authors:  Adam Mor; Mark R Philips
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

4.  Perifosine, an oral bioactive novel alkylphospholipid, inhibits Akt and induces in vitro and in vivo cytotoxicity in human multiple myeloma cells.

Authors:  Teru Hideshima; Laurence Catley; Hiroshi Yasui; Kenji Ishitsuka; Noopur Raje; Constantine Mitsiades; Klaus Podar; Nikhil C Munshi; Dharminder Chauhan; Paul G Richardson; Kenneth C Anderson
Journal:  Blood       Date:  2006-01-17       Impact factor: 22.113

5.  CXCR4 physically associates with the T cell receptor to signal in T cells.

Authors:  Ashok Kumar; Troy D Humphreys; Kimberly N Kremer; Patricia S Bramati; Lavone Bradfield; Contessa E Edgar; Karen E Hedin
Journal:  Immunity       Date:  2006-08       Impact factor: 31.745

Review 6.  Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.

Authors:  Shuyu Li; Shuguang Huang; Sheng-Bin Peng
Journal:  Int J Oncol       Date:  2005-11       Impact factor: 5.650

7.  Stromal cell-derived factor-1alpha stimulates tyrosine phosphorylation of multiple focal adhesion proteins and induces migration of hematopoietic progenitor cells: roles of phosphoinositide-3 kinase and protein kinase C.

Authors:  J F Wang; I W Park; J E Groopman
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

8.  Antimyeloma activity of heat shock protein-90 inhibition.

Authors:  Constantine S Mitsiades; Nicholas S Mitsiades; Ciaran J McMullan; Vassiliki Poulaki; Andrew L Kung; Faith E Davies; Gareth Morgan; Masaharu Akiyama; Reshma Shringarpure; Nikhil C Munshi; Paul G Richardson; Teru Hideshima; Dharminder Chauhan; Xuesong Gu; Charles Bailey; Marie Joseph; Towia A Libermann; Neal S Rosen; Kenneth C Anderson
Journal:  Blood       Date:  2005-10-18       Impact factor: 22.113

9.  Zebrafish G protein gamma2 is required for VEGF signaling during angiogenesis.

Authors:  Tinchung Leung; Hui Chen; Anna M Stauffer; Kathryn E Giger; Soniya Sinha; Eric J Horstick; Jasper E Humbert; Carl A Hansen; Janet D Robishaw
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

10.  Clinical significance of chemokine receptor (CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival.

Authors:  Isabelle Vande Broek; Isabelle Van de Broek; Xavier Leleu; Rik Schots; Thiery Facon; Karin Vanderkerken; Ben Van Camp; Ivan Van Riet
Journal:  Haematologica       Date:  2006-02       Impact factor: 9.941

View more
  168 in total

1.  Myeloma as a model for the process of metastasis: implications for therapy.

Authors:  Irene M Ghobrial
Journal:  Blood       Date:  2012-04-24       Impact factor: 22.113

2.  In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins.

Authors:  M Martínez-Moreno; M Leiva; N Aguilera-Montilla; S Sevilla-Movilla; S Isern de Val; N Arellano-Sánchez; N C Gutiérrez; R Maldonado; J Martínez-López; I Buño; J A García-Marco; P Sánchez-Mateos; A Hidalgo; A García-Pardo; J Teixidó
Journal:  Leukemia       Date:  2015-12-10       Impact factor: 11.528

Review 3.  The bone-marrow niche in MDS and MGUS: implications for AML and MM.

Authors:  Irene M Ghobrial; Alexandre Detappe; Kenneth C Anderson; David P Steensma
Journal:  Nat Rev Clin Oncol       Date:  2018-01-09       Impact factor: 66.675

Review 4.  Pathogenesis beyond the cancer clone(s) in multiple myeloma.

Authors:  Giada Bianchi; Nikhil C Munshi
Journal:  Blood       Date:  2015-04-02       Impact factor: 22.113

5.  The Akt pathway regulates survival and homing in Waldenstrom macroglobulinemia.

Authors:  Xavier Leleu; Xiaoying Jia; Judith Runnels; Hai T Ngo; Anne-Sophie Moreau; Mena Farag; Joel A Spencer; Costas M Pitsillides; Evdoxia Hatjiharissi; Aldo Roccaro; Garrett O'Sullivan; Douglas W McMillin; Daisy Moreno; Tanyel Kiziltepe; Ruben Carrasco; Steven P Treon; Teru Hideshima; Kenneth C Anderson; Charles P Lin; Irene M Ghobrial
Journal:  Blood       Date:  2007-08-30       Impact factor: 22.113

6.  The CXCR4-SDF1alpha axis is a critical mediator of rhabdomyosarcoma metastatic signaling induced by bone marrow stroma.

Authors:  Brigitte Strahm; Adam D Durbin; Elizabeth Sexsmith; David Malkin
Journal:  Clin Exp Metastasis       Date:  2007-09-01       Impact factor: 5.150

7.  microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.

Authors:  Aldo M Roccaro; Antonio Sacco; Changzhong Chen; Judith Runnels; Xavier Leleu; Feda Azab; Abdel Kareem Azab; Xiaoying Jia; Hai T Ngo; Molly R Melhem; Nicholas Burwick; Lyuba Varticovski; Carl D Novina; Barrett J Rollins; Kenneth C Anderson; Irene M Ghobrial
Journal:  Blood       Date:  2008-12-12       Impact factor: 22.113

8.  Cutaneous localization in multiple myeloma in the context of bortezomib-based treatment: how do myeloma cells escape from the bone marrow to the skin?

Authors:  Valentina Marchica; Fabrizio Accardi; Paola Storti; Cristina Mancini; Eugenia Martella; Benedetta Dalla Palma; Marina Bolzoni; Katia Todoerti; Magda Marcatti; Chiara Schifano; Sabrina Bonomini; Gabriella Sammarelli; Antonino Neri; Maurilio Ponzoni; Franco Aversa; Nicola Giuliani
Journal:  Int J Hematol       Date:  2016-10-03       Impact factor: 2.490

9.  Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone disease.

Authors:  Rakesh Bam; Wen Ling; Sharmin Khan; Angela Pennisi; Sathisha Upparahalli Venkateshaiah; Xin Li; Frits van Rhee; Saad Usmani; Bart Barlogie; John Shaughnessy; Joshua Epstein; Shmuel Yaccoby
Journal:  Am J Hematol       Date:  2013-03-28       Impact factor: 10.047

Review 10.  Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma.

Authors:  H Quach; D Ritchie; A K Stewart; P Neeson; S Harrison; M J Smyth; H M Prince
Journal:  Leukemia       Date:  2009-11-12       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.